Sofie van Koppen, A Maryse Minnaard, Johanna A S Smeets, Iulia Buzatouiu, Geert M J Ramakers, Roger A H Adan, Louk J M J Vanderschuren, Heidi M B Lesscher
{"title":"Seeking under threat of adversity: assessing control over reward pursuit in rats.","authors":"Sofie van Koppen, A Maryse Minnaard, Johanna A S Smeets, Iulia Buzatouiu, Geert M J Ramakers, Roger A H Adan, Louk J M J Vanderschuren, Heidi M B Lesscher","doi":"10.1007/s00213-024-06729-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Rationale: </strong>Substance use disorder (SUD) is a chronic relapsing brain disorder that is characterised by loss of control over substance use. A variety of rodent models employing punishment setups have been developed to assess loss of control over substance use, i.e. persistent substance use despite negative consequences, to facilitate the translation of findings from animal studies to the human situation.</p><p><strong>Objectives: </strong>Since the negative consequences of addictive behaviour are typically unpredictable, we here present the Seeking under Threat of Adversity (STA) task in rats, that incorporates cued, probabilistic and response-contingent punishment of reward seeking.</p><p><strong>Methods: </strong>Male rats were trained to lever press for sucrose, alcohol or cocaine and were subsequently tested in the STA task. In this task, a tone cue is presented during reward seeking which functions as a warning signal, since responding during tone presentation results in a probabilistic foot shock punishment. We first determined the optimal shock intensity to induce a moderate suppression of seeking. Next, we assessed the stability of punished reward seeking over repeated tests. Finally, we compared the development of loss of control over substance seeking for sucrose, alcohol and cocaine. (Loss of) control over substance seeking would be evident as the (in)ability to refrain from lever pressing to obtain a reward, despite the threat of a negative outcome.</p><p><strong>Results: </strong>Parametric experiments revealed suppression of responding for both sucrose and alcohol in the STA task at shock intensities between 0.25 and 0.35 mA. The suppression of responding was stable with repeated testing. Furthermore, less control over alcohol and cocaine seeking, when compared to sucrose seeking, was observed in male rats using the STA task.</p><p><strong>Conclusions: </strong>The STA task is a novel behavioural task that includes two important aspects of human substance use despite negative consequences, i.e. response contingency and unpredictability of adversity. Combined with other behavioural tasks and neural manipulations, the STA task can further our understanding of the psychopathology of substance use disorders.</p>","PeriodicalId":20783,"journal":{"name":"Psychopharmacology","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00213-024-06729-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Rationale: Substance use disorder (SUD) is a chronic relapsing brain disorder that is characterised by loss of control over substance use. A variety of rodent models employing punishment setups have been developed to assess loss of control over substance use, i.e. persistent substance use despite negative consequences, to facilitate the translation of findings from animal studies to the human situation.
Objectives: Since the negative consequences of addictive behaviour are typically unpredictable, we here present the Seeking under Threat of Adversity (STA) task in rats, that incorporates cued, probabilistic and response-contingent punishment of reward seeking.
Methods: Male rats were trained to lever press for sucrose, alcohol or cocaine and were subsequently tested in the STA task. In this task, a tone cue is presented during reward seeking which functions as a warning signal, since responding during tone presentation results in a probabilistic foot shock punishment. We first determined the optimal shock intensity to induce a moderate suppression of seeking. Next, we assessed the stability of punished reward seeking over repeated tests. Finally, we compared the development of loss of control over substance seeking for sucrose, alcohol and cocaine. (Loss of) control over substance seeking would be evident as the (in)ability to refrain from lever pressing to obtain a reward, despite the threat of a negative outcome.
Results: Parametric experiments revealed suppression of responding for both sucrose and alcohol in the STA task at shock intensities between 0.25 and 0.35 mA. The suppression of responding was stable with repeated testing. Furthermore, less control over alcohol and cocaine seeking, when compared to sucrose seeking, was observed in male rats using the STA task.
Conclusions: The STA task is a novel behavioural task that includes two important aspects of human substance use despite negative consequences, i.e. response contingency and unpredictability of adversity. Combined with other behavioural tasks and neural manipulations, the STA task can further our understanding of the psychopathology of substance use disorders.
期刊介绍:
Official Journal of the European Behavioural Pharmacology Society (EBPS)
Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:
Human Psychopharmacology: Experimental
This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.
Human Psychopharmacology: Clinical and Translational
This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.
Preclinical psychopharmacology: Behavioral and Neural
This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.
Preclinical Psychopharmacology: Translational
This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.
Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic
This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.